Interconversion of two commonly used performance tools: An analysis of 5844 paired assessments in 1501 lung cancer patients

about

Interconversion of two commonly used performance tools: An analysis of 5844 paired assessments in 1501 lung cancer patients

Item

http://www.wikidata.org/entity/Q58695709

description

scientific article published on 01 November 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Interconversion of two commonl ...... s in 1501 lung cancer patients

@en

Interconversion of two commonl ...... s in 1501 lung cancer patients

@nl

type

Item

label

Interconversion of two commonl ...... s in 1501 lung cancer patients

@en

Interconversion of two commonl ...... s in 1501 lung cancer patients

@nl

prefLabel

Interconversion of two commonl ...... s in 1501 lung cancer patients

@en

Interconversion of two commonl ...... s in 1501 lung cancer patients

@nl

P1476

Interconversion of two commonl ...... s in 1501 lung cancer patients

@en

P2093

Ashutosh Nath Aggarwal

http://www.w3.org/2001/XMLSchema#string

Digambar Behera

http://www.w3.org/2001/XMLSchema#string

Harpreet Kaur

http://www.w3.org/2001/XMLSchema#string

Kuruswamy Thurai Prasad

http://www.w3.org/2001/XMLSchema#string

Navneet Singh

http://www.w3.org/2001/XMLSchema#string

Valliappan Muthu

http://www.w3.org/2001/XMLSchema#string

P2860

The Measurement of Observer Agreement for Categorical Data

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Association of Graded Folic Acid Supplementation and Total Plasma Homocysteine Levels With Hematological Toxicity During First-line Treatment of Nonsquamous NSCLC Patients With Pemetrexed-based Chemotherapy.

Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution.

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.

Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation

Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care.

Quantified smoking status and non-small cell lung cancer stage at presentation: analysis of a North Indian cohort and a systematic review of literature.

Performance status score: do patients and their oncologists agree?

Management of advanced lung cancer in resource-constrained settings: a perspective from India.

P304

140-147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5306/WJCO.V9.I7.140

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30425939

http://www.w3.org/2001/XMLSchema#string

P932

6230919

http://www.w3.org/2001/XMLSchema#string